Deutsches Krebsforschungszentrum
Candidate genes in breast tumors identified through matrix-CGH analysis
Published in Pharma Law Weekly, March 15th, 2005
In a recent study from Germany, "[g]enomic imbalances in 31 formalin-fixed and paraffin-embedded primary tumors of advanced breast cancer were analyzed by microarray-based comparative genomic hybridization (matrix-CGH)."
"A DNA chip was designed comprising 422 mapped genomic sequences including 47 proto-oncogenes, 15 tumor suppressor genes, as well as frequently imbalanced chromosomal regions," explained M. Nessling and coauthors at the Deutsches Krebsforschungszentrum in Heidelberg. "Analysis of the data was challenging due to the impaired quality of DNA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2005-03-15)
More Articles from Pharma Law Weekly
- Akesis Pharmaceuticals, Inc.
Fourth U.S. patent issued to pharma firm for treatment of diabetes - American Physical Therapy Association
Members of Congress support affordable rehabilitation services under Medicare - BioVeris Corporation
Agreement reached for license to patent rights for vaccine candidates - ChemGenex Pharmaceuticals
Company receives European patent allowance for cancer drug, Quinamed - Critical Therapeutics, Inc.
Company initiates phase II study of CTI-01; receives CTI-01 U.S. patent - Drug Abuse
Woman offers daughter as 'sad face of meth' - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
